![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Pioneering mRNA technology - Moderna
Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Our Story - Moderna
We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
Company Culture - Moderna
Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.
Investor Relations Overview - Moderna
Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.
Our Mission & Values - Moderna
Moderna people hold a deep sense of responsibility for each other, patients, the environment and our local communities. Our people live our Values every day.
Moderna R&D Day Highlights Progress and Strategic Priorities
Sep 12, 2024 · Looking ahead to 2026-2028, Moderna will expand its commercial portfolio with first-in-class vaccines and therapeutics to address non-respiratory diseases, including cytomegalovirus, norovirus, propionic acidemia, methylmalonic acidemia, and melanoma. Updates from Moderna's late-stage portfolio and approved vaccines include:
Pioneering mRNA technology - Moderna Australia
Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
Our Mission & Values - Moderna
Moderna's Mindsets “We believe our mRNA platform can solve the world’s greatest health challenges, from diseases impacting millions, to ultra-rare diseases impacting dozens, to medicines personalized down to the individual level.”
Moderna Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 · Moderna intends to file in 2024 for approval of its next-generation COVID-19 vaccine (mRNA-1283) and RSV vaccine (mRNA-1345) for high-risk adults aged 18-59; the Company expects to communicate the PDUFA date for each of …
Pioneering mRNA technology - Moderna
Learn more about the science behind mRNA and how Moderna's scientists are researching and developing investigational mRNA medicines to potentially help prevent or treat disease.